ETR:SRT - Sartorius Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
€123.50 +0.50 (+0.41 %)
(As of 07/22/2018 04:00 PM ET)
Previous Close€123.50
Today's Range€120.50 - €125.50
52-Week RangeN/A
Volume341 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Sartorius logoSartorius Aktiengesellschaft provides pharmaceutical and laboratory equipment worldwide. The company operates through two divisions, Bioprocess Solutions, and Lab Products & Services. The Bioprocess Solutions division offers products, technologies, and services ranging from fermentation, cell cultivation, filtration, and purification to media storage and transportation for the biopharmaceutical industry. It provides filtration and purification, sterile filtration, virus filtration, crossflow filtration, harvesting, prefiltration, membrane chromatography, air/gas filtration, integrity testing, and OEM membranes; process analyzers, process control tools, microbiology products, and chemometric software; single-use bioprocess bags, containers, mixing systems, aseptic transfer systems, freeze and thaw systems, aseptic sampling and bottle closure systems, and tubing dis-/connectors; media USP and buffers DSP; bioreactors/fermentors; and FlexAct, a system that enables to custom-configure single-use solutions for entire biomanufacturing steps. The Lab Products & Services division provides laboratory instruments, such as lab balances, pipettes, and laboratory water purification systems; and consumables, including laboratory filters and pipette tips. Its products include OEM weigh cells, mass comparators and metrology, weights/weight sets, and paint mixing solutions; microbiology products and moisture analyzers; lab water systems; pipette tips and pipette calibration; bioreactors/fermentors and centrifuges; and filtration, ultrafiltration, membrane chromatography products, virus purification kits, diagnostic membranes and arrays, and blotting membranes, as well as aseptic bottle closure systems. The company also offers instrument, validation, and training services. It serves biopharmaceutical and pharmaceutical, public research institutes, and chemical and food sectors. The company was founded in 1870 and is headquartered in Goettingen, Germany.

Receive SRT News and Ratings via Email

Sign-up to receive the latest news and ratings for SRT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange ETR
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
SymbolETR:SRT
CUSIPN/A
PhoneN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00

Sartorius (ETR:SRT) Frequently Asked Questions

What is Sartorius' stock symbol?

Sartorius trades on the ETR under the ticker symbol "SRT."

What price target have analysts set for SRT?

5 brokerages have issued twelve-month price objectives for Sartorius' shares. Their predictions range from €94.00 to €141.00. On average, they expect Sartorius' share price to reach €114.00 in the next year. This suggests that the stock has a possible downside of 7.7%. View Analyst Ratings for Sartorius.

What is the consensus analysts' recommendation for Sartorius?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sartorius in the last year. There are currently 2 sell ratings and 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold."

Who are some of Sartorius' key competitors?

Who are Sartorius' key executives?

Sartorius' management team includes the folowing people:
  • Dr. Joachim Kreuzburg, Chairman of Exec. Board & CEO (Age 53)
  • Mr. Reinhard Vogt, Member of the Exec. Board (Age 63)
  • Mr. Rainer Lehmann, Member of Exec. Board (Age 42)
  • Ms. Petra Kirchhoff, VP of Corp. Communications & Investor Relations and Member of Supervisory Board (Age 49)
  • Mr. Manfred Werner, Sr. VP of Admin. Organization & Auditing

Has Sartorius been receiving favorable news coverage?

Press coverage about SRT stock has trended somewhat positive this week, Accern reports. The research group rates the sentiment of media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Sartorius earned a news sentiment score of 0.10 on Accern's scale. They also assigned media coverage about the company an impact score of 46.32 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

What is Sartorius' stock price today?

One share of SRT stock can currently be purchased for approximately €123.50.


MarketBeat Community Rating for Sartorius (ETR SRT)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  8 (Vote Outperform)
Underperform Votes:  13 (Vote Underperform)
Total Votes:  21
MarketBeat's community ratings are surveys of what our community members think about Sartorius and other stocks. Vote "Outperform" if you believe SRT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SRT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.